EQA Scheme
Contact
Virus Immunology - HIV-1 p24 Antigen (337)
Samples:
2 samples of 0.75 ml
Sample properties:
Liquid serum
Additional Information:
For POCT systems: Please ensure that the sample matrix used in the EQA scheme is suitable for your test system. In case of uncertainty, we recommend contacting the manufacturer or supplier of your device.
Requirement for EQAS/PT according to Rili-BÄK
Parameters:
HIV-1 p24 Ag, HIV-1 p24 Ag Confirmation test
Certificate Validity: 12 months
Not subject to Rili-BÄK
Parameters:
not applicable
Certificate Validity: not applicable
Shipping Information:
Shipping not cooled
Safety Information:
Process as patient sample material. The participating laboratory must be authorized to perform direct and/or indirect detection of pathogens.
Dates:
Registration deadline:
Sample shipment:
Closing Date:
| Mar. (2) | June (4) | Sep. (5) | Nov. (6) |
|---|---|---|---|
| 08.01.2027 | 09.04.2027 | 25.06.2027 | 03.09.2027 |
| 09.03.2027 | 08.06.2027 | 24.08.2027 | 02.11.2027 |
| 26.03.2027 | 25.06.2027 | 10.09.2027 | 19.11.2027 |
EQAS/PT Experts:
Dr. rer. nat. Rolf Kaiser, Dipl.-Biol.
Institut für Virologie
Universität und Universitätsklinikum zu Köln
Fürst-Pückler-Straße 56
50935 Köln
+49 221 478-85808
rolf.kaiser@uk-koeln.de
Dr. rer. nat. Martin Kammel
Institut für Qualitätssicherung in der Virusdiagnostik - IQVD
Potsdamer Chaussee 80
14129 Berlin
+49 30 8105 4300
m.kammel@iqvd.de